News
EW
77.17
-3.49%
-2.79
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Seeking Alpha · 12h ago
Weekly Report: what happened at EW last week (0504-0508)?
Weekly Report · 23h ago
Edwards Lifesciences Shareholders Approve Expanded Equity Incentive Plan
TipRanks · 3d ago
Is It Time To Reassess Edwards Lifesciences (EW) After Mixed Returns And Rich P/E Ratio
Simply Wall St · 5d ago
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Fortrea Holdings Inc. (FTRE) and Edwards Lifesciences (EW)
TipRanks · 6d ago
Edwards Lifesciences (EW) Gets a Buy from Piper Sandler
TipRanks · 6d ago
Edwards Lifesciences Appoints Theodora Mistras As Chief Financial Officer
NASDAQ · 05/05 05:25
Top Edwards Lifesciences Executive Makes Notable Insider Move
TipRanks · 05/05 02:01
Viatris CFO Mistras Departs for Edwards Lifesciences
Dow Jones · 05/04 23:35
Edwards Lifesciences Announces New Chief Financial Officer Appointment
TipRanks · 05/04 22:46
Edwards Lifesciences names new CFO
Seeking Alpha · 05/04 20:53
Edwards Lifesciences appoints Theodora Mistras as CFO
TipRanks · 05/04 20:47
*Edwards Lifesciences: Mistras to Succeed Scott Ullem at End of May
Dow Jones · 05/04 20:46
*Edwards Lifesciences Names Theodora Mistras as Financial Chief
Dow Jones · 05/04 20:46
*Edwards Lifesciences Announces Appointment Of CFO >EW
Dow Jones · 05/04 20:45
Weekly Report: what happened at EW last week (0427-0501)?
Weekly Report · 05/04 09:48
Edwards Lifesciences Maintained at Buy as Strong Q1 Results and RESILIA Durability Data Support Elevated 2026 Outlook and Unchanged $97 Price Target
TipRanks · 05/04 03:57
Edwards Lifesciences announces 10-year results from Commence aortic trial
TipRanks · 05/03 17:30
Will Strong 10‑Year RESILIA Data and Higher 2026 Guidance Change Edwards Lifesciences' (EW) Narrative?
Simply Wall St · 05/02 20:33
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
Barchart · 05/02 10:50
More
Webull provides a variety of real-time EW stock news. You can receive the latest news about Edwards Lifesciences Corp through multiple platforms. This information may help you make smarter investment decisions.
About EW
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.